Peterborough, Canada Clinical Trials

A listing of Peterborough, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 72 clinical trials
None
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

The purpose of this study is to evaluate the long-term safety and maintenance of efficacy of mirikizumab in participants with moderate-to-severe plaque psoriasis.

mirikizumab
plaque psoriasis
SKiN Centre for Dermatology
 (1.9 away) Contact site
  • 730 views
  • 25 Nov, 2021
  • +367 other locations
None
Long-Term PF-06651600 for the Treatment of Alopecia Areata

This is a global Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called PF-06651600) in adults and adolescents (12 years and older) who have alopecia areata. Eligible patients from the prior studies B7931005 (NCT02974868) and B7981015 (NCT03732807) will have an opportunity to enroll as …

alopecia totalis
pf-06651600
areata alopecia
alopecia universalis
alopecia
SKiN Centre for Dermatology
 (1.9 away) Contact site
  • 1703 views
  • 10 Oct, 2021
  • +177 other locations
None
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults without a prior myocardial infarction (MI) or stroke who are at high risk of a cardiovascular event.

stroke
arterial disease
myocardial infarction
diabetes
infarct
Research Site
 (0.6 away) Contact site
  • 542 views
  • 27 Nov, 2021
  • +1350 other locations
None
A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation

This is a randomized, double-blind, placebo-controlled study in patients with dilated cardiomyopathy (DCM) due to a mutation of the gene encoding the lamin A/C protein (LMNA). The study will further evaluate a dose level of study drug (ARRY-371797) that has shown preliminary efficacy and safety in this patient population. After …

walk test
cardiac resynchronization therapy
dilated cardiomyopathy
implantable cardioverter defibrillator
implantable cardioverter-defibrillators
Array Investigative Site
 (0.0 away) Contact site
  • 422 views
  • 27 Nov, 2021
  • +261 other locations
None
A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease

A phase 2 randomized, double blind, placebo controlled study evaluating the efficacy and safety of AL002 in participants with Early Alzheimer's Disease.

alzheimer's disease
mini-mental state examination
amyloidosis
Kawartha Regional Memory Clinic
 (0.2 away) Contact site
  • 2 views
  • 22 Sep, 2021
  • +85 other locations
None
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis

The main purpose of this study is to characterize the long-term safety and efficacy of the drug Deucravacitinib (BMS-986165) in patients who have been previously enrolled in an applicable Phase 3 psoriasis study.

bms-986165
Skin Centre for Dermatology
 (1.9 away) Contact site
  • 382 views
  • 18 Nov, 2021
  • +338 other locations
None
Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa

The purpose of this extension study is to evaluate maintenance of HiSCR response at Week 104 in either continuous or interrupted therapy (using a randomized withdrawal period) of two dose regimens and to assess long-term efficacy, safety and tolerability of secukinumab in subjects with moderate to severe hidradenitis suppurativa completing …

hidradenitis
secukinumab
expanded access trial
Novartis Investigative Site
 (1.9 away) Contact site
  • 75 views
  • 26 Aug, 2021
  • +170 other locations
None
OLE of Phase 2b/3 Study ANAVEX2-73-AD-004

This is a Phase 2b/3 open-label extension study to evaluate the effects of ANAVEX2-73 on safety and effficacy of daily treatment.

Kawartha Centre
 (0.2 away) Contact site
  • 50 views
  • 13 Apr, 2021
  • +49 other locations
None
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

body mass index
hemoglobin a1c
cardiovascular disease
Kawartha Cardiology Clinical Trials
 (0.6 away) Contact site
  • 643 views
  • 26 Nov, 2021
  • +913 other locations
None
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease. Additional participants will be enrolled to an addendum safety cohort. The participants will be administered open-label donanemab.

flortaucipir
mini-mental state examination
florbetapir
alzheimer's disease
positron emission tomography
Kawartha Regional Memory Clinic
 (0.2 away) Contact site
  • 531 views
  • 25 Nov, 2021
  • +399 other locations